Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

We’re here for one reason and one reason only - to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.

Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.

Job Description

We are seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role reports to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline.

This role will be office-based/hybrid (3 days onsite) in El Segundo or Thousand Oaks or Foster City, CA.

In this position, you will be a critical Global Value & Access partner for Kite's growing autoimmune cell therapy portfolio. You will lead the development and execution of global market access strategies to support early and late-stage development programs, while preparing for future launches of transformative cell therapies across autoimmune diseases.

You will work closely with Global Clinical Development, Medical Affairs, HEOR/RWE, Commercial, Regulatory Affairs and regional Access teams to ensure payer perspectives are incorporated into development decisions and launch planning. You will play a key role in shaping evidence generation strategies that support differentiated value propositions, reimbursement, and patient access across major global markets.

Key Responsibilities

Strategic Market Access Leadership

• Serve as the Global Market Access representative for assigned autoimmune programs and contribute to cross-functional conversations.

• In the Value Access Sub-Team, you will be leading and partnering with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure efficient integration of Access input into the Portfolio Strategy.

• Lead the development of global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.

• Ensure payer, HTA, and health system perspectives are reflected in development, evidence generation, pricing, and commercialization strategies.

• Partner with regional and country access teams to develop integrated global-to-local reimbursement strategies.

Asset Development and Evidence Generation

• Analyze market access trends, evolving reimbursement requirements, competitive dynamics, and health system considerations across major markets including the US, EU5, Canada, Australia, and Japan.

• Provide market access input into target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and evidence generation plans.

• Advise development teams on evidence requirements needed to support future reimbursement, pricing, and formulary access decisions.

• Ensure access-relevant considerations are incorporated into development milestones and governance decisions.

Value Demonstration and HEOR Partnership

• Partner with Clinical, HEOR, RWE and Medical Affairs to develop and execute early payer engagement and HTA scientific advice strategies across multiple autoimmune indications, ensuring payer perspectives are incorporated into evidence generation and development plans.

• Provide strategic leadership on US market access dynamics across autoimmune indications, including payer formulary management, utilization management (e.g., step edits and prior authorization), and rebate contracting strategies, ensuring these considerations are proactively incorporated into development, evidence generation, pricing, and launch planning.

• Lead cross-functional assessment of payer, HTA, and health system evidence requirements across key global markets, translating insights into actionable recommendations for clinical development programs.

• Assess the access implications of development opportunities across autoimmune indications and advise governance teams on the likelihood of achieving favorable pricing, reimbursement, and patient access outcomes.

• Partner with HEOR, RWE, Medical Affairs, and Commercial teams to develop compelling value propositions and evidence packages.

• Advise on the development of economic models, burden-of-illness studies, indirect treatment comparisons, and other payer-focused evidence.

Cross-Functional Leadership

• Act as the market access lead within cross-functional teams, ensuring alignment across Development, Medical Affairs, Commercial, Regulatory Affairs, Pricing, and HEOR.

• Influence strategic decisions through robust assessment of payer expectations, reimbursement risks, and value opportunities.

Basic Qualifications

8+ years with a PhD/ PharmD

OR

10+ years with MS/MA, MBA, PharmD, PhD or equivalent advanced degree

OR

12+ years with BS/BA

Preferred Qualifications

• 3+ years of direct experience supporting autoimmune disease programs, including development-stage assets, clinical strategy, market access, medical affairs, commercial strategy, or related functions.

• Deep understanding of autoimmune disease treatment paradigms, competitive dynamics, and unmet patient needs.

• Experience in advanced therapies, including cell therapy and/or gene therapy, strongly preferred.

• Experience supporting market access, pricing, reimbursement, HEOR, commercial strategy, or related functions within the pharmaceutical or biotechnology industry.

• Experience supporting early and/or late-stage development programs and translating payer insights into development decisions.

• Demonstrated experience incorporating payer, HTA, and health system requirements into clinical development and evidence generation strategies.

• Experience supporting launch readiness activities, global launch planning, and lifecycle management.

• Strong understanding of global payer, pricing, reimbursement, and HTA landscapes.

• Experience partnering with HEOR, RWE, Medical Affairs, Clinical Development, and Commercial functions to develop value evidence strategies.

• Understanding of value frameworks, reimbursement pathways, and evidence requirements across major global markets.

• Demonstrated ability to influence cross-functional teams in a matrix environment.

• Strong strategic thinking, analytical, and problem-solving skills.

• Excellent communication skills and experience presenting to senior leadership.

• Proven ability to collaborate across functions, regions, cultures, and time zones.

• Ability to thrive in a fast-paced environment characterized by innovation and portfolio growth.

People Leader Accountabilities

• Create Inclusion: Know the business value of diverse teams, model inclusive leadership, and foster an environment where diversity and belonging drive innovation and performance.

• Develop Talent: Understand the skills, experiences, aspirations, and potential of employees and provide coaching and development opportunities to help them grow and achieve their career goals.

• Empower Teams: Align teams to organizational priorities, remove barriers, encourage accountability, and create an environment where individuals can do their best work.

The salary range for this position is:

Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

For additional benefits information, visit:

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

For jobs in the United States:

Kite Pharmais committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, geneticinformation or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact [email protected] for assistance.

For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT

YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

Kite Pharma will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the legal duty to furnish information; or (d) otherwise protected by law.

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Kite Pharmaprovides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Kite Pharma Employees and Contractors:

Please apply via the Internal Career Opportunities portal in Workday.